ACRS
Aclaris Therapeutics Inc
NASDAQ: ACRS · HEALTHCARE · BIOTECHNOLOGY
$4.47
+5.92% today
Updated 2026-04-29
Market cap
$624.30M
P/E ratio
—
P/S ratio
79.77x
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$1 – $5
Volume
2.0M
Aclaris Therapeutics Inc (ACRS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $1.68M | $10.09M | $4.23M | $6.48M | $6.76M | $29.75M | $31.25M | $18.72M | $7.83M |
| Revenue growth (YoY) | — | — | — | — | — | +499.6% | -58.1% | +53.3% | +4.3% | +340.1% | +5.0% | -40.1% | -58.2% |
| Cost of revenue | — | $0.00 | $90000.00 | $120000.00 | $1.21M | $6.85M | $4.05M | $5.13M | $4.71M | $11.96M | $18.08M | $2.79M | $2.09M |
| Gross profit | — | $0.00 | $-90000.00 | $-120000.00 | $476000.00 | $3.24M | $172000.00 | $1.35M | $2.05M | $17.79M | $13.17M | $15.93M | $5.74M |
| Gross margin | — | — | — | — | 28.3% | 32.1% | 4.1% | 20.8% | 30.3% | 59.8% | 42.1% | 85.1% | 73.3% |
| R&D | $3.49M | $6.51M | $15.34M | $33.48M | $39.79M | $63.01M | $64.90M | $31.73M | $43.81M | $77.81M | $98.38M | $33.59M | $52.65M |
| SG&A | $1.77M | $2.03M | $5.33M | $15.09M | $33.11M | $27.65M | $27.16M | $20.53M | $23.62M | $25.13M | $31.10M | $22.20M | $21.97M |
| Operating income | $-5.26M | $-8.53M | $-20.67M | $-48.57M | $-72.42M | $-135.41M | $-111.06M | $-50.91M | $-89.72M | $-89.85M | $-97.36M | $-141.93M | $-76.38M |
| Operating margin | — | — | — | — | -4303.2% | -1341.9% | -2627.3% | -785.4% | -1327.1% | -302.0% | -311.6% | -758.2% | -975.9% |
| EBITDA | $-5.25M | $-8.52M | $-20.58M | $-48.45M | $-72.02M | $-133.53M | $-90.23M | $-49.59M | $-64.46M | $-84.36M | $-115.45M | $-51.72M | $-64.47M |
| EBITDA margin | — | — | — | — | -4279.3% | -1323.3% | -2134.7% | -765.0% | -953.4% | -283.5% | -369.5% | -276.3% | -823.8% |
| EBIT | $-5.26M | $-8.53M | $-20.67M | $-48.57M | $-72.42M | $-135.41M | $-91.82M | $-50.91M | $-65.38M | $-85.15M | $-116.31M | $-52.53M | $-64.92M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.04M | $23.42M | $4.70M | — | — | — |
| Income tax | — | $0.00 | $-90000.00 | $-120000.00 | $-1.83M | $2.68M | $29.31M | $-182000.00 | $23.42M | $1.75M | $-367000.00 | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.4% | 0.2% | 2.6% | -2.1% | -22.2% | 0.4% | -34.7% | -2.1% | 0.4% | 0.0% | 0.0% |
| Net income | $-5.24M | $-8.52M | $-20.56M | $-48.08M | $-68.52M | $-132.74M | $-161.35M | $-51.15M | $-90.86M | $-86.91M | $-88.48M | $-132.06M | $-64.92M |
| Net income growth (YoY) | — | -62.7% | -141.4% | -133.8% | -42.5% | -93.7% | -21.6% | +68.3% | -77.6% | +4.4% | -1.8% | -49.3% | +50.8% |
| Profit margin | — | — | — | — | -4071.5% | -1315.4% | -3817.2% | -789.2% | -1344.0% | -292.1% | -283.1% | -705.5% | -829.6% |